TAT-QFNP12 acetate is a polypeptide that inhibits the binding of NDRG2-PPM1A and reduces the phosphorylation of Smad2/3, leading to a decrease in the production of MMP-9 in astrocytes and mitigating blood-brain barrier disruption following subarachnoid hemorrhage (SAH).
Target-Kategorie:
MMP|||TGF-beta/Smad
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
